CoChat
Sign Up
Cited by 492Blood Coagulation and Thrombosis MechanismsPregnancy and preeclampsia studiesBlood properties and coagulation

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Hemostasis during Normal Pregnancy and Puerperium

Hellgren, Margareta·2003·Seminars in Thrombosis and Hemostasis
DOI 10.1055/s-2003-38897
Open this paper in CoChat — free account

Abstract

During normal pregnancy the hemostatic balance changes in the direction of hypercoagulability, thus decreasing bleeding complications in connection with delivery. The most important initial factor for acute hemostasis at delivery is, however, uterine muscle contractions, which interrupt blood flow. Global tests such as Sonoclot signature, the Thromboelastogram, and a new method analyzing overall plasma hemostasis, all show changes representative of hypercoagulability during pregnancy. Increased endogenous thrombin generation, acquired activated protein C resistance, slightly decreased activated partial thromboplastin time (aPTT) and increased prothrombin complex level (PT) measured as international normalized ratio (INR) of less than 0.9 have been reported as well. In normal pregnancy, the platelet count is within normal range except during the third trimester when benign gestational thrombocytopenia, 80 to 150 x 10 9/L, can be observed. Platelet turnover is usually normal. Activation of platelets and release of beta-thromboglobulin and platelet factor 4 are reported. The bleeding time is unchanged during normal pregnancy. Most blood coagulation factors and fibrinogen increase during pregnancy. Factor (F) XI is the only blood coagulation factor that decreases. Blood coagulation inhibitors are mainly unchanged but the level of free protein S decreases markedly and the level of tissue factor pathway inhibitor increases. Thrombomodulin levels increase during pregnancy. Fibrinolytic capacity is diminished during pregnancy, mainly because of markedly increased levels of plasminogen activator inhibitor-1 (PAI-1) from endothelial cells and plasminogen activator inhibitor-2 (PAI-2) from the placenta. Thrombin-activated fibrinolysis inhibitor is reported to be unaffected. The total hemostatic balance has been studied by analyses of prothrombin fragment 1+2, thrombin-antithrombin complex, fibrinopeptide A, soluble fibrin, D-dimer, and plasmin-antiplasmin complex. There is activation of blood coagulation and a simultaneous increase in fibrinolysis without signs of organ dysfunction during normal pregnancy. These changes increase as pregnancy progresses. During delivery, there is consumption of platelets and blood coagulation factors, including fibrinogen. Fibrinolysis improves and increases fast following childbirth and expulsion of the placenta, resulting in increased D-dimer levels. These changes are self-limiting at normal delivery. The hemostatic changes, noted during pregnancy, normalize after delivery within 4 to 6 weeks. Platelet count and free protein S, however, can be abnormal longer. Hemostasis should not be tested earlier than 3 months following delivery and after terminating lactation to rule out influences of pregnancy. PAI-1 and PAI-2 levels decrease fast postpartum, but PAI 2 has been detected up to 8 weeks postpartum. alpha 2 -antiplasmin, urokinase, and kallikrein inhibitor levels have been reported to be increased 6 weeks postpartum.

Overview

Integrity signals

Registry

Crossref · 10.1055/s-2003-38897

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 29 references

Cited by

Sorted by citations

Items 401–490 of 490

Related

See all

Metadata

Authors
Hellgren, M.
Affiliations
Sahlgrenska University Hospital (SE)
Corresponding author
Hellgren, Margareta
Venue
Seminars in Thrombosis and Hemostasis
Publisher
Georg Thieme Verlag KG
Published
2003
Volume
29
Issue
2
Pages
125-130
ISSN
  • 0094-6176 (ISSN-L)
  • 1098-9064
DOI
10.1055/s-2003-38897
OpenAlex
W2088909125
Cited by
492
References
29
Citations by year
2026: 20 · 2025: 25 · 2024: 38 · 2023: 31 · 2022: 30 · 2021: 25 · 2020: 21 · 2019: 19 · 2018: 23 · 2017: 21 · 2016: 27 · 2015: 23 · 2014: 28 · 2013: 13 · 2012: 24
FWCI
5.12
Type
journal article
Language
en
Open access
closed
Locations
  • Seminars in Thrombosis and Hemostasis (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Health Sciences › Medicine › Hematology › Blood properties and coagulation
Keywords
hemostasis, pregnancy, postpartum period, hypercoagulability, thrombosis, uterine contraction, activated protein C resistance, gestational thrombocytopenia, fibrinolysis, plasminogen activator inhibitor-1, D-dimer, thrombomodulin, tissue factor pathway inhibitor, free protein S
MeSH terms
Blood Coagulation Tests, Female, Hemostasis, Humans, Platelet Function Tests, Pregnancy, Biomarkers, Thrombophilia, Postpartum Period

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review